Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of DLBS1449 in Diabetic Patients With Low HDL-Cholesterol - Double Blind Comparative Study With Placebo

NCT01972477 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT01972477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of DLBS1449 in Diabetic Patients With Low HDL-Cholesterol - Double Blind Comparative Study With Placebo
Lead sponsor
Dexa Medica Group
Phase
Phase 2/3
Overall status
Withdrawn
Start date
July 31, 2016
Completion date
January 31, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic patients, lifestyle intervention for at least 1 month, low hdl-cholesterol (< 35 mg/dl)